4.4 Article

Delivery of daunorubicin to cancer cells with decreased toxicity by association with a lipidic nanoemulsion that binds to LDL receptors

Related references

Note: Only part of the references are listed.
Review Pharmacology & Pharmacy

Evaluation in melanoma-bearing mice of an etoposide derivative associated to a cholesterol-rich nanoemulsion

Ana C. Lo Prete et al.

JOURNAL OF PHARMACY AND PHARMACOLOGY (2006)

Review Oncology

Pathogenesis of cardiotoxicity induced by anthracyclines

Perry Elliott

SEMINARS IN ONCOLOGY (2006)

Article Pharmacology & Pharmacy

Effects on Walker 256 tumour of carmustine associated with a cholesterol-rich microemulsion (LDE)

RS Teixeira et al.

JOURNAL OF PHARMACY AND PHARMACOLOGY (2004)

Article Engineering, Biomedical

The production and characteristics of solid lipid nanoparticles (SLNs)

DZ Hou et al.

BIOMATERIALS (2003)

Article Pharmacology & Pharmacy

Use of a cholesterol-rich microemulsion that binds to low-density lipoprotein receptors as vehicle for etoposide

CJ Valduga et al.

JOURNAL OF PHARMACY AND PHARMACOLOGY (2003)

Article Oncology

Uptake of a cholesterol-rich emulsion by breast cancer

SR Graziani et al.

GYNECOLOGIC ONCOLOGY (2002)

Article Biology

In vitro cytotoxicity of the LDE:daunorubicin complex in acute myelogenous leukemia blast cells

PE Dorlhiac-Llacer et al.

BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2001)

Article Oncology

Uptake of a cholesterol-rich emulsion by neoplastic ovarian tissues

A Ades et al.

GYNECOLOGIC ONCOLOGY (2001)